280 related articles for article (PubMed ID: 27781369)
21. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome.
Beckers AB; Weerts ZZRM; Helyes Z; Masclee AAM; Keszthelyi D
Aliment Pharmacol Ther; 2017 Nov; 46(10):938-952. PubMed ID: 28884838
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
23. Blockade of BK channels attenuates chronic visceral hypersensitivity in an IBS-like rat model.
Fan F; Chen Y; Chen Z; Guan L; Ye Z; Tang Y; Chen A; Lin C
Mol Pain; 2021; 17():17448069211040364. PubMed ID: 34407673
[TBL] [Abstract][Full Text] [Related]
24. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
[TBL] [Abstract][Full Text] [Related]
25. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
Elsenbruch S
Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
[TBL] [Abstract][Full Text] [Related]
26. Modulation of human visceral sensitivity by noninvasive magnetoelectrical neural stimulation in health and irritable bowel syndrome.
Algladi T; Harris M; Whorwell PJ; Paine P; Hamdy S
Pain; 2015 Jul; 156(7):1348-1356. PubMed ID: 25867123
[TBL] [Abstract][Full Text] [Related]
27. Early-life adversity, epigenetics, and visceral hypersensitivity.
Liu S; Hagiwara SI; Bhargava A
Neurogastroenterol Motil; 2017 Sep; 29(9):. PubMed ID: 28782197
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of Stress-Induced Visceral Pain: Implications in Irritable Bowel Syndrome.
Greenwood-Van Meerveld B; Moloney RD; Johnson AC; Vicario M
J Neuroendocrinol; 2016 Aug; 28(8):. PubMed ID: 26749172
[TBL] [Abstract][Full Text] [Related]
29. Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.
Botschuijver S; van Diest SA; van Thiel IAM; Saia RS; Strik AS; Yu Z; Maria-Ferreira D; Welting O; Keszthelyi D; Jennings G; Heinsbroek SEM; Elferink RPO; Schuren FHJ; de Jonge WJ; van den Wijngaard RM
Sci Rep; 2019 Aug; 9(1):12530. PubMed ID: 31467355
[TBL] [Abstract][Full Text] [Related]
30. [Research progress in the relationship between TRPV1 and visceral hypersensitivity in functional gastrointestinal diseases].
Li S; Duan LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):311-4. PubMed ID: 21503132
[TBL] [Abstract][Full Text] [Related]
31. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.
Farzaei MH; Bahramsoltani R; Abdollahi M; Rahimi R
J Neurogastroenterol Motil; 2016 Oct; 22(4):558-574. PubMed ID: 27431236
[TBL] [Abstract][Full Text] [Related]
32. Differential visceral pain sensitivity and colonic morphology in four common laboratory rat strains.
O'Malley D; Julio-Pieper M; O'Mahony SM; Dinan TG; Cryan JF
Exp Physiol; 2014 Feb; 99(2):359-67. PubMed ID: 24243837
[TBL] [Abstract][Full Text] [Related]
33. Hippocampal NR2B-containing NMDA receptors enhance long-term potentiation in rats with chronic visceral pain.
Chen Y; Chen AQ; Luo XQ; Guo LX; Tang Y; Bao CJ; Lin L; Lin C
Brain Res; 2014 Jun; 1570():43-53. PubMed ID: 24824341
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in pharmacological research on the management of irritable bowel syndrome.
Nam Y; Min YS; Sohn UD
Arch Pharm Res; 2018 Oct; 41(10):955-966. PubMed ID: 30132170
[TBL] [Abstract][Full Text] [Related]
35. Piezo2 channels expressed by colon-innervating TRPV1-lineage neurons mediate visceral mechanical hypersensitivity.
Xie Z; Feng J; Hibberd TJ; Chen BN; Zhao Y; Zang K; Hu X; Yang X; Chen L; Brookes SJ; Spencer NJ; Hu H
Neuron; 2023 Feb; 111(4):526-538.e4. PubMed ID: 36563677
[TBL] [Abstract][Full Text] [Related]
36. Visceral and somatic hypersensitivity, autonomic cardiovascular dysfunction and low-grade inflammation in a subset of irritable bowel syndrome patients.
Liu L; Liu BN; Chen S; Wang M; Liu Y; Zhang YL; Yao SK
J Zhejiang Univ Sci B; 2014 Oct; 15(10):907-14. PubMed ID: 25294380
[TBL] [Abstract][Full Text] [Related]
37. Early-life stress-induced visceral hypersensitivity and anxiety behavior is reversed by histone deacetylase inhibition.
Moloney RD; Stilling RM; Dinan TG; Cryan JF
Neurogastroenterol Motil; 2015 Dec; 27(12):1831-6. PubMed ID: 26403543
[TBL] [Abstract][Full Text] [Related]
38. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
[TBL] [Abstract][Full Text] [Related]
39. Role of sympathetic nervous system in rat model of chronic visceral pain.
Gil DW; Wang J; Gu C; Donello JE; Cabrera S; Al-Chaer ED
Neurogastroenterol Motil; 2016 Mar; 28(3):423-31. PubMed ID: 26670784
[TBL] [Abstract][Full Text] [Related]
40. Irritable Bowel Syndrome: A Clinical Review.
Cashman MD; Martin DK; Dhillon S; Puli SR
Curr Rheumatol Rev; 2016; 12(1):13-26. PubMed ID: 26717952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
